Angelo Palmas

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Michèle Cavo, Francesca Gay, Meral Beksaç et al. · The Lancet Haematology · 2020 · 384 citations · Full text

Medicine, Hematology, Oncology +17

Bacteria-Eradicating Therapy With Doxycycline in Ocular Adnexal MALT Lymphoma: A Multicenter Prospective Trial

Andrés J.M. Ferreri, Maurilio Ponzoni, Massimo Guidoboni et al. · JNCI Journal of the National Cancer Institute · 2006 · 209 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Late‐onset noninfectious pulmonary complications after allogeneic bone marrow transplantation

Angelo Palmas, Ayalew Tefferi, Jeffrey L. Myers et al. · British Journal of Haematology · 1998 · 198 citations

Medicine, Clinical Sciences, Immunology +13

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial

Roberto Mina, Pellegrino Musto, Delia Rota‐Scalabrini et al. · The Lancet Oncology · 2022 · 85 citations · Full text

Medicine, Hematology, Oncology +17

Cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) gene polymorphism and susceptibility to non‐Hodgkin's lymphoma

Maria Monne, Giovanna Piras, Angelo Palmas et al. · American Journal of Hematology · 2004 · 76 citations

Life Sciences, Genetics, Molecular Genetics +17